Ticker Details
Kyverna Therapeutics, Inc. Common Stock
IPO Date:	February 9, 2024
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$579.16M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.34 | 4.46%
Avg Daily Range (30 D):	$0.31 | 3.67%
Avg Daily Range (90 D):	$0.36 | 4.30%

Institutional Daily Volume
Avg Daily Volume:	.5M
Avg Daily Volume (30 D):	.59M
Avg Daily Volume (90 D):	1.08M

Trade Size
Avg Trade Size (Sh.):	95
Avg Trade Size (Sh.) (30 D):	79
Avg Trade Size (Sh.) (90 D):	91

Institutional Trades
Total Institutional Trades:	148
Avg Institutional Trade:	$1.77M
Avg Institutional Trade (30 D):	$1.28M
Avg Institutional Trade (90 D):	$1.09M
Avg Institutional Trade Volume:	.17M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.41M
Avg Closing Trade (30 D):	$2.76M
Avg Closing Trade (90 D):	$1.25M
Avg Closing Volume:	242.95K

News

Feb 24, 2026 @ 1:00 PM Kyverna Therapeutics Appoints Biotech Leaders Srav... Source: Na

Dec 31, 2025 @ 3:01 PM How M&A Unlocked A Biotech Rebound In 2025—... Source: Namrata Sen

Dec 17, 2025 @ 2:24 PM Kyverna Therapeutics Announces Pricing of $100 Mil... Source: Globe Newswire

Dec 15, 2025 @ 11:20 PM Stock Market Today, Dec. 15: U.S Stocks Ease as In... Source: Eric Trie

Dec 14, 2025 @ 7:30 PM Kyverna Therapeutics to Report Topline Results fro... Source: Kyverna Therapeutics

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-3.64	$-.79	$-3.64
Diluted EPS	$-3.64	$-.79	$-3.64
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-161.31M	$-37.8M	$-161.31M
Operating Income / Loss	$-169.83M	$-39.28M	$-169.83M
Cost of Revenue
Net Cash Flow	$27.47M	$89.93M	$27.47M
PE Ratio